One of the most rewarding aspects of being in oncology is the close link between research and clinical advances. Year by year, there’s more that I can offer patients — the standard of care constantly evolves, and new treatments and medications emerge. Much of what drew me to SCCA were the clinical research opportunities at the Fred Hutch/University of Washington Cancer Consortium. The consortium gathers experts from Fred Hutch, University of Washington, SCCA and other partner organizations to accelerate scientific breakthroughs. It’s a remarkable opportunity to translate discoveries into new and better treatments for my patients with lung cancer.
I approach every patient the way that I would want my own family members to be treated. I made that promise to myself a long time ago, and I come to work every day fulfilling that promise. I pair every patient’s unique goals and circumstances with the latest scientific advances in order to provide a personalized approach to care. Being a part of each patient’s journey is incredibly meaningful to me.
Area of clinical practice
Head and neck cancers, thoracic cancers
Lung cancer, head and neck cancers
I am a board-certified medical oncologist who specializes in the treatment of lung cancer, head and neck cancers, mesothelioma and thymic cancer. In addition to providing clinical care, I have over a decade of scientific experience in cancer immunology, a field of study that examines the relationship between the immune system and cancer cells. Our immune system has evolved to respond to viruses and other pathogens, and it’s only recently that we’ve harnessed the immune system — in the form of immunotherapies — to target cancer. My primary research interest is investigating what factors drive individual responses to immunotherapies so that we can give every patient the best possible chance in their fight against lung cancer.
Stanford University School of Medicine
Massachusetts General Hospital, Internal Medicine
Stanford University School of Medicine, Medical Oncology
Internal Medicine, 2016; Medical Oncology, 2019, American Board of Internal Medicine
PhD, Cancer Biology, Stanford University School of Medicine
Conquer Cancer Foundation Young Investigator Award
Dr. Tseng received this award in 2018 to study lung cancer immunology. Sponsored by the foundation of the American Society of Clinical Oncology, this award offers funding to promising young cancer researchers.
Lung Cancer Research Foundation Award
Dr. Tseng received this grant in 2018 for conducting innovative research focused on the diagnosis and treatment of lung cancer.
Lung Cancer Specialized Programs of Research Excellence (SPORE) Career Enhancement Program
Dr. Tseng received this grant in 2020 for her research project studying the relationship between the way the immune system responds to tumors and the way it responds to environmental pathogens in patients with lung cancer.
At Fred Hutch, you receive care from a team of providers with extensive experience in your disease. Your team includes doctors, a patient care coordinator, a registered nurse, an advanced practice provider and others, based on your needs. You also have access to experts like nutritionists, social workers, acupuncturists, psychiatrists and more who specialize in supporting people with cancer or blood disorders.
Fred Hutch accepts most national private health insurance plans as well as Medicare. We also accept Medicaid for people from Washington, Alaska, Montana and Idaho. We are working to ensure that everyone, no matter what their financial situation, has access to the care they need.